Physician profile
Brian Bechtold
NPI 1003882598
$3,718.79
in general payments reported to CMS, 2019-2025
21 companies · $693 in 2025
The $693 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $553 · 2022: $1,160 · 2023: $773 · 2024: $540 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $845.65 | 2021-2023 | Aveir |
| Janssen Pharmaceuticals, INC | $501.16 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $474.43 | 2021-2025 | |
| Heartflow, INC. | $433.68 | 2022-2025 | Ffrct |
| Amgen INC. | $322.37 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $307.67 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $211.28 | 2022-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $161.06 | 2022 | |
| Pfizer INC. | $107.67 | 2022-2025 | |
| Amarin Pharma, INC. | $67.65 | 2021 | |
| Bridgebio Pharma, INC. | $64.02 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals Lp | $47.52 | 2024-2025 | Farxiga |
| Lexicon Pharmaceuticals, INC. | $31.51 | 2023-2024 | Inpefa |
| Abbvie INC. | $28.99 | 2022 | |
| Cleerly, INC. | $21.33 | 2025 | Cleerly Ischemia, Cleerly Labs |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $18.63 | 2025 | Amvuttra |
| Philips North America LLC | $18.15 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.56 | 2025 | |
| Kiniksa Pharmaceuticals, Ltd. | $14.29 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $13.86 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bechtold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.